Active Ingredients
Mycoplasma
Porcine circovirus
Description
For use in healthy swine as an aid in the prevention of viremia, aid in the reduction of virus shedding and aid in the reduction of lymphoid infection caused by porcine circovirus type 2 (PCV 2), and as an aid in the reduction of lung lesions due to Mycoplasma hyopneumoniae. PCV 2 efficacy for at least 20 weeks following completion of vaccination has been demonstrated.